Home LiteratureArticle Details
PMID: 1727653 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Role of endogenous fatty acids in the control of hepatic gluconeogenesis.

Archives of biochemistry and biophysics ·Vol. 292 ·No. 1 ·1992-01-00 ·Pages 95-101

González-Manchón C, Martín-Requero A, Ayuso MS, Parrilla R

Abstract

Inhibition of endogenous long chain fatty acids oxidation by tetradecylglycidate (TDGA) impeded gluconeogenesis from lactate or from low concentrations of pyruvate (less than 0.5 mM). The inhibitory effect of TDGA was overcome by medium and short chain fatty acid or by concentrations of pyruvate about 0.5 mM, but not by 10-fold higher concentrations of lactate. Despite decreased energy demand when gluconeogenesis was inhibited by TDGA, the pyruvate-induced increase in hepatic oxygen consumption was similar to the control, indicating that pyruvate transport across the mitochondrial membrane and/or its decarboxylation was not altered, and therefore can not be responsible for the inhibition of gluconeogenesis. Neither does a deficiency of acetyl-CoA explain the decrease in the gluconeogenic flux since high pyruvate loads (greater than 0.5 mM), beta-hydroxybutyrate or even ethanol was capable of overcoming the inhibitory effect of TDGA in the absence of significant changes in the hepatic content of acetyl-CoA. At low (less than 0.3 mM), presumably physiological, pyruvate concentrations, its rate of mitochondrial utilization is limited by the activity of the monocarboxylate transporter. Agents that reduced the mitochondrial NAD system, and therefore reduced flux through pyruvate dehydrogenase, like beta-hydroxybutyrate or ethanol, stimulated gluconeogenesis when fatty acid oxidation was inhibited. The latter observations indicate that the primary role of endogenous fatty acid, when substrate availability is limiting, is to spare mitochondrial pyruvate by decreasing its oxidation, and therefore shifting the partitioning between the carboxylation and decarboxylation reactions toward the former.

MeSH Terms
3-Hydroxybutyric Acid Animals Epoxy Compounds/pharmacology Fatty Acids/pharmacology,physiology Fatty Acids, Volatile/pharmacology Gluconeogenesis/drug effects Hydroxybutyrates/pharmacology Liver/drug effects,metabolism,physiology Male NAD Oxidation-Reduction/drug effects Pyruvates/metabolism Pyruvic Acid Rats Rats, Inbred Strains
Chemicals
Epoxy Compounds Fatty Acids Fatty Acids, Volatile Hydroxybutyrates Pyruvates NAD Pyruvic Acid 2-tetradecylglycidic acid 3-Hydroxybutyric Acid
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
González-Manchón C
Endocrine Physiology Unit, Centro de Investigaciones Biológicas (CSIC), Madrid, Spain.
Martín-Requero A
Ayuso M S
Parrilla R
Article Info
Journal
Archives of biochemistry and biophysics
Abbr.
Arch Biochem Biophys
ISSN
0003-9861
Published
1992-01-00
Pages
95-101
Language
English
Region
United States
NLM ID
0372430
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com